BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market
July 24, 2023 11:30 ET
|
BioNexus Gene Lab Corp.
KUALA LUMPUR, Malaysia, July 24, 2023 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BioNexus” or the “Company”) (Nasdaq: BGLC), an emerging company in the business of selling chemical raw materials...
Optimi Health Corp. Receives Receipt For Final Prospectus and Conditional Approval to List on the CSE
February 18, 2021 15:18 ET
|
Optimi Health Corp.
NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (“Optimi” or the “Company”),...
Neo Performance Materials Inc. Files Final Prospectus and Announces Pricing of Initial Public Offering
December 04, 2017 17:00 ET
|
Neo Performance Materials Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Neo Performance Materials Inc. (the "Company") announced today...